Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response of Estriol/Trimegestone Vaginal Rings
NCT03343912Phase 1Completed
- Sponsor
- Galeno Research Center
- Start
- Nov 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of estriol and trimegestone in contraception (3 arms), sponsored by Galeno Research Center. Primary endpoints: Estradiol and Progesterone Plasma Levels and Estriol and Trimegestone Plasma Levels. Started Nov 2017; status: completed.
02
Drugs
estrioltrimegestone
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03343912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03343912.